Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,794.00
Bid: 6,778.00
Ask: 6,780.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.03%)
Open: 6,886.00
High: 6,919.00
Low: 6,736.00
Yest. Close: 6,880.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca prices four-tranche $3bn global bond offering

(Sharecast News) - AstraZeneca priced a four-tranche global bond offering totalling $3bn on Tuesday, it announced on Wednesday morning.

15 Aug 18 08:56

Sector movers: Miners, Big Oil and pharma lead gains

(Sharecast News) - Commodity-related stocks paced gains on Tuesday following the release of figures overnight showing that China's foreign exchange reserves didn't jump last month.

7 Aug 18 18:16

AstraZeneca, Merck NF1 treatment granted orphan status by EMA

(Sharecast News) - AstraZeneca and Merck said the European Medicines Agency (EMA) has granted orphan designation to selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1) an incurable genetic condition that affects one in 3,000 newborns worldwide.

3 Aug 18 07:52

PRESS: Sanofi and Novartis Plan Pre-Brexit Drug Stockpile In UK - FT

LONDON (Alliance News) - Sanofi SA and Novartis AG have joined other companies in making plans for building a pre-Brexit drug stockpile, the Financial Times reported on Wednesday.Sanofi Fry

2 Aug 18 14:11

AstraZeneca's lung cancer treatment gains positive opinion from CHMP

(Sharecast News) - AstraZeneca on Friday received a marketing authorisation for its lung cancer treatment Imfinzi from the committee for medicinal products for human use (CHMP).

27 Jul 18 14:53

AstraZeneca Granted European Approval For Lung Cancer Treatment

LONDON (Alliance News) - AstraZeneca PLC said Friday that the European Medicines Agency committee had recommended market authorisation for its lung cancer treatment.The Committee for for a

27 Jul 18 14:33

LONDON MARKET CLOSE: Shell Decline Leaves FTSE Trailing European Peers

LONDON (Alliance News) - Stocks in London ended mixed on Thursday amid a torrent of UK company earnings, as declines from heavyweight Royal Dutch Shell left the FTSE 100 lagging behind European The a

26 Jul 18 17:06

LONDON MARKET MIDDAY: Stocks Flat Amid Results Deluge Ahead Of ECB

LONDON (Alliance News) - Stock prices in London were flat at midday as investors absorbed Thursday's bounty of company results.Gains for reporting firms British America Tobacco,

26 Jul 18 12:04

WINNERS & LOSERS SUMMARY: BAT On Fire After Half Year Earnings Surge

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------British up a

26 Jul 18 10:55

LONDON MARKET OPEN: BAT, Astra Gain While Compass, Shell, Diageo Fall

LONDON (Alliance News) - Stocks in London were higher on Thursday as investors digested a heaping plate of earnings from blue-chip companies such as Royal Dutch Shell, American and a

26 Jul 18 08:39

TOP NEWS: Astra Backs Guidance Despite First-Half Revenue, Profit Fall

LONDON (Alliance News) - AstraZeneca PLC on Thursday reported a fall in interim revenue and profit, but held its annual guidance.Total revenue for the first half of the year fell 1% at down

26 Jul 18 07:53

LONDON MARKET PRE-OPEN: Shell, Diageo Unveil Buybacks; Sky Profit Up

LONDON (Alliance News) - Stock prices in London are set to edge higher on Thursday, with focus on the latest monetary policy decision from the European Central Bank, amid a jam-packed day for company

26 Jul 18 07:38

TOP NEWS: AstraZeneca Sells Atacand European Rights For USD210 Million

LONDON (Alliance News) - AstraZeneca PLC said on Tuesday it has agreed to sell the commercial rights to Atacand and Atacand Plus in Europe to pharmaceutical products developer Cheplapharm is a for

24 Jul 18 07:53

AstraZeneca offloads Atacand rights in $200m deal

(Sharecast News) - AstraZeneca has agreed to sell the commercial rights to Atacand - candesartan cilexetil - and Atacand Plus - a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide - in Europe to Cheplapharm Arzneimittel, it announced on Tuesday.

24 Jul 18 07:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 20 July Acacia MiningHalf Year Results BeazleyHalf Year GroupTrading

19 Jul 18 16:19

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.